Clinical Trials Browser

Phase 1 × INDUSTRY × Homoharringtonine × Clear all

NCT01844869 2015-01-30

An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms

NCT00675350 2014-05-12

Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors

Phase 1 Completed

Hematologic Tumors